ClinicalTrials.gg
RecruitingNCT06904768SLS-StrokeUpdated Apr 1, 2025

Effect of Shoulder Sling Use on Balance and Mobility in Subacute Stroke Patients

An interventional study of Shoulder Sling and No Sling in Hemiplegia, Balance Disorders and Mobility Limitation, sponsored by Arnaoutis Stylianos. Recruiting at 1 site in Greece. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-04-01.

Sponsored by Arnaoutis Stylianos · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Primary completion was expected by Apr 2025, 1 year 7 months ago, but the record still lists the study as recruiting.
  • Started Mar 2025; still recruiting 1 year 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
17
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study examines whether wearing a shoulder sling can improve balance and mobility in people who are recovering from a stroke. Participants will perform simple movement and balance tests twice-once with the sling and once without. The goal is to find out if using the sling helps patients feel more stable and safe during walking and everyday activities.

Read the detailed description

This is a cross-over study designed to evaluate the impact of shoulder sling use on balance and functional mobility in patients recovering from stroke in the subacute phase. Participants will be asked to complete three validated functional tests: the Timed Up and Go (TUG) test, the Functional Reach Test (FRT), and the Modified Four Square Step Test (mFSST). Each test will be performed twice, once with the shoulder sling and once without, in randomized order. The study aims to determine whether the sling provides measurable benefits in stability and performance during movement tasks. Data will be collected in rehabilitation centers under the supervision of clinical researchers.

02

Conditions studied

  • Hemiplegia
  • Balance Disorders
  • Mobility Limitation
  • Shoulder Subluxation
  • Stroke

Keywords

  • Stroke
  • Hemiplegia
  • mobility
  • dynamic balance
  • balance
  • shoulder brace
  • arm sling
03

In context

Hemiplegia

450 studies on the registry are indexed under Hemiplegia; 92 are open to participants now.

This study's planned enrollment of 17 is below the median of 34 across 373 interventional studies indexed under Hemiplegia.

Browse Hemiplegia studies →

Lead sponsor

This is the only study on the registry with Arnaoutis Stylianos as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Clinical diagnosis of stroke in the subacute phase (up to 6 months post-onset)
  • Hemiplegia affecting one upper limb
  • Brunnstrom stage \< 4 for the affected upper limb
  • Functional Ambulation Category (FAC) score > 3
  • Age between 40 and 80 years
  • Ability to follow simple instructions
  • Medically stable to participate in balance and mobility testing
  • Signed

Exclusion criteria

Exclusion Criteria:

  • Severe cognitive impairment (e.g. \< 23)
  • Visual or vestibular disorders affecting balance
  • Significant orthopedic or musculoskeletal conditions of the lower limbs
  • Uncontrolled cardiovascular or pulmonary disease
  • Use of assistive devices that prevent sling application
  • Severe aphasia interfering with understanding or communication
  • Skin lesions or injuries at the shoulder region preventing sling use
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
17 participants (estimated)

Study arms

  • Experimental
    Shoulder Sling

    Participants perform balance and mobility tests (TUG, FRT, mFSST) while wearing a shoulder sling on the affected upper limb.

    Device: Shoulder Sling

  • Active comparator
    No Sling

    The same functional tests are performed without the use of a shoulder sling.

    Other: No Sling

Interventions

  • DeviceShoulder Sling

    Use of a shoulder sling (Reh4mat AM-SOB) on the affected upper limb during mobility and balance testing.

  • OtherNo Sling

    Functional mobility tests performed without the use of any assistive shoulder device.

06

What researchers measure

Primary outcomes

  1. Timed Up and Go (TUG) Test

    Time required (in seconds) to stand up from a chair, walk 3 meters, turn, walk back, and sit down.

    Time frame: Within 1 day (each participant performs it twice - with and without sling)

  2. Functional Reach Test (FRT)

    Distance reached (in centimeters) while standing and reaching forward without losing balance.

    Time frame: Within 1 day (each participant performs it twice - with and without sling)

  3. Modified Four Square Step Test (mFSST)

    Time required to step in all four quadrants in a specified sequence.

    Time frame: Within 1 day (each participant performs it twice - with and without sling)

07

Study locations

1 of 1 sites recruiting
  • Filoktitis Recovery and Rehabilitation Center
    Koropi, Attica 19441, Greece
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2025 (actual). Primary completion is estimated for Apr 2025, 1 month after the start.

Of 226 non-industry interventional studies with no phase under Hemiplegia, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 27. This study's planned 1 month is below that.

Counting every sponsor, half of 231 studies reached it within 12 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 23, 2025
First posted
Apr 1, 2025
StartActual
Mar 13, 2025
Primary completionEst.
Apr 2025
CompletionEst.
Apr 2025
Last update
Apr 1, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06904768
Lead sponsor
Arnaoutis Stylianos
Collaborators
University of West Attica
Responsible party
Arnaoutis Stylianos (Principal Investigator, University of West Attica) — Sponsor-investigator
First posted
Apr 1, 2025
Start date
Mar 13, 2025
Primary completion
Apr 2025 (estimated)
Completion
Apr 2025 (estimated)
Last update
Apr 1, 2025

Study contacts

Stylianos Arnaoutis
Contact
mscphys23001@uniwa.gr
+306981199528
Stylianos Arnaoutis
Contact
mscphys23001@uniwa.gr
6981199528
Nikolaos Chrysagis
study chair · University of West Attica

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion